InsiderClue
Insiders · Profile

Reilly Thomas Charles

Chief Financial Officer at Tvardi Therapeutics. Filing since 30 Aug 2021. CIK 0001827590

Company
Date
Role
Action
Shares
Amount
Of holding
TVRD Tvardi Therapeutics, Inc.
3 Mar 2022
Chief Financial Officer
Sold, plan not stated
2,044
$23.26K
5.1%
TVRD Tvardi Therapeutics, Inc.
30 Aug 2021
Chief Financial Officer
Sold, plan not stated
1,982
$28.14K
37.2%
2 decisions on file.